


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+2.85%
-0.55%
-11.21%
+2.18%
BLTE
Belite Bio Inc
$120.37
Strengths

Upgraded on attractively valued
Chart
$92 (+30.84%)
$64.2 (+87.49%)
$59.47 (+102.40%)
$64 (+88.08%)
BLTE has Moderate risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Low volume

BLTE overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Loss widens YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future
![]()
BLTE Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
BLTE Street Sentiment is bullish and have negative views on the near-term outlook
Average key support and resistance price levels.
Login to displayWhat is BLTE current stock price?
What are BLTE stock strengths?
What is BLTE Risk Level?
What is BLTE market cap and volume?
What is BLTE current Stock IQ?
Should I buy BLTE stock right now?
Is BLTE a Strong Buy right now?
What does a 'Strong Buy' rating mean for BLTE?
What does a 'Strong Sell' rating mean for BLTE?
What factors influence BLTE's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+2.85%
-0.55%
-11.21%
+2.18%
BLTE
Belite Bio Inc
Current Price
$120.37
Stock Insights
Strengths

Upgraded on attractively valued

Chart
$92 (+30.84%)
$64.2 (+87.49%)
$59.47 (+102.40%)
$64 (+88.08%)
BLTE Analysts Opinion
BLTE Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Loss widens YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future
![]()
BLTE Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
BLTE Street Sentiment is bullish and have negative views on the near-term outlook
BLTE has Moderate risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Low volume

Average key support and resistance price levels.
BLTE Latest Analysis
Belite Bio Inc - Depositary Receipt (BLTE) Price Target Increased by 21.98% to 116.02. The average one-year price target for Belite Bio Inc - Depositary Receipt (NasdaqCM:BLTE) has been revised to $116.02 / share. This is an increase of 21.98% from the prior estimate of $95.12 dated November 7 2025. The price target is an average of many targe
Tue Nov 18, 2025
Dry Age-related Macular Degeneration Market Poised for Rapid Growth During the Forecast Period (2025–2034) Amid Expanding Treatment Landscape | DelveInsight. Dry Age-related Macular Degeneration Market Poised for Rapid Growth During the Forecast Period (2025–2034) Amid Expanding Treatment Landscape |. DelveInsightThe overall dry AMD market size in the US is anticipated to increase due to the uptake of recently approved therapies the launch of emerging therapies such as Gildeuretinol (Alkeus
Mon Nov 17, 2025
Belite Bio Inc Q3 Loss Increases . (RTTNews) - Belite Bio Inc (BLTE) reported Loss for its third quarter of -$21.69 million
Mon Nov 10, 2025
Belite Bio Inc (BLTE) Presents at Deutsche Bank ADR Virtual Investor Conference 2025 - Slideshow.
Tue Nov 4, 2025
Belite Bio Inc (BLTE) Presents at Deutsche Bank ADR Virtual Investor Conference 2025 Prepared Remarks Transcript.
Tue Nov 4, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
BLTE Stock trends
BLTE Stock performance
BLTE Stock analysis
BLTE investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.